Reproductive Genetics Global Market Report 2023: Increasing Demand for Genetic Testing Bolsters Growth


Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Reproductive Genetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Component (Laboratory Developed Tests, Kits & Assays, Reagents & Consumables), By Technology, By Procedure Type, By Application, By Region and Competition" report has been added to's offering.

The global reproductive genetics market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing awareness of genetic engineering in developing countries to get better.

Additionally, growing reimbursement improvements for medical tests and initiatives, running parallel to multiple investments by government organizations for developing new diagnostic centers, have significantly increased the demand for reproductive genetics across different parts of the globe.

Additionally, significant growth in advanced testing, along with increasing awareness among different age groups of women for a leading safe life, is further expected to increase the demand for reproductive genetics, thereby fuelling the market growth through 2027.

Furthermore, increasing focus on family planning, favorable regulations by the government, and advancements in different testing are further expected to increase the demand for reproductive genetics, thereby supporting market growth. Similarly, advancement in geno9mic technologies and implementation of this technology in clinical medicine will enhance the usage in genetic disorder testing, carrier screening, and identification of infertility which will further boost the growth of the market during the forecast period.

Increasing Demand for Genetic Testing

Increasing demand for genetic testing of embryos, either during pregnancy or of those created through IVF to check for possible genetic disorders, is driving the growth of the reproductive genetics market. Increasing genetic testing for embryos through IVF technology and several developments in genetic testing are making it possible to test for genetic disorders in artificial reproduction, which is driving the market growth during the forecast period.

Reproductive genetics help to identify embryo defects so that parents can adopt alternative procedures like IVF, thus increasing the healthy pregnancy and baby regardless of patient health, which will further boost the market during the forecast period. According to Statista, as of 2019, the leading state by the number of legal abortions in the United States was New York, which reported over 78 thousand abortions that year. Florida also reported over 71 thousand abortions, followed by Texas with over 57 thousand. There was a total of 630000 legal abortions in the United States in 2019.

Growing Advancement in Genomic Technologies

Increasing advancement in genomic technologies and further implementation of these technologies in clinical medicine have enhanced their usage in the diagnosis of genetic disorders, carrier screening, and identification of the cause of infertility, propelling the market growth in the forecast period. Some tests are much more expensive, which helps couples from going ahead with the tests. However, with the decline in the cost of sequencing and the surge in the mixed-ethnicity population, an increasing number of couples/individuals are expected to opt for the new procedure, which is expected to drive the market growth during the forecast period. Birth defects affect one in every 33 babies (about 3% of all babies) born in the United States each year.

Report Scope:

In this report, global reproductive genetics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Reproductive Genetics Market, By Component:

  • Laboratory-Developed Tests
  • Kits & Assays
  • Reagents & Consumables

Reproductive Genetics Market, By Technology:

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • In Situ Hybridization, Microarrays

Reproductive Genetics Market, By Procedure Type:

  • Carrier Screening
  • Prenatal Screening
  • Preimplantation Genetic Testing
  • Infertility Genetic Testing

Reproductive Genetics Market, By Application:

  • Aneuploidy
  • Single Gene Disorder
  • Structural Chromosomal Abnormality
  • Others

Reproductive Genetics Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Egypt

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Reproductive Genetics Market Outlook

6. North America Reproductive Genetics Market Outlook

7. Europe Reproductive Genetics Market Outlook

8. Asia-Pacific Reproductive Genetics Market Outlook

9. South America Reproductive Genetics Market Outlook

10. Middle East and Africa Reproductive Genetics Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Competitive Landscape

14. Strategic Recommendations

A selection of companies mentioned in this report includes

  • CooperSurgical, Inc.
  • Centogene AG
  • Invitae Corporation
  • Illumina, Inc.
  • Myriad Genetics, Inc.,
  • Thermo Fisher Scientific Inc.
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics
  • Natera, Inc
  • Eurofins Scientific SE

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.